Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Brain Res. 2017 Oct 24;1678:123–128. doi: 10.1016/j.brainres.2017.10.024

Fig. 2.

Fig. 2

30% FeCl3 induced MCAO experiments. Systemic LB1 administration, 2 hours after ischemia, significantly decreased infarct volume at 24 hours of stroke (A). A representative infarct picture with TTC staining of LB1 treated brain (inset). NSS were in favor of LB1 treated group (B). Weight loss of treatment group was significantly lower compared to vehicle injected group (C).

HHS Vulnerability Disclosure